Cargando…
Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells
BACKGROUND: Chemotherapy is a primary approach in cancer treatment after routine surgery. However, chemo-resistance tends to occur with chemotherapy in clinic, resulting in poor prognosis and recurrence. Nowadays, Chinese medicine may shed light on design of new therapeutic modes to overcome chemo-r...
Autores principales: | Zhong, Zhangfeng, Yu, Haibing, Wang, Shengpeng, Wang, Yitao, Cui, Liao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114245/ https://www.ncbi.nlm.nih.gov/pubmed/30181769 http://dx.doi.org/10.1186/s13020-018-0203-z |
Ejemplares similares
-
Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein
por: Wang, Shengpeng, et al.
Publicado: (2014) -
Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: He, Luying, et al.
Publicado: (2022) -
Sources, morphology, phytochemistry, pharmacology of Curcumae Longae Rhizoma, Curcumae Radix, and Curcumae Rhizoma: a review of the literature
por: Zhu, Xin, et al.
Publicado: (2023) -
Inhibition of Fibroblast Activation in Uterine Leiomyoma by Components of Rhizoma Curcumae and Rhizoma Sparganii
por: Feng, Yewen, et al.
Publicado: (2021) -
Pharmacokinetic Comparisons of Typical Constituents in Curcumae Rhizoma and Vinegar-Processed Curcumae Rhizoma after Oral Administration to Rats
por: Gu, Wei, et al.
Publicado: (2018)